Westchester Capital Management (New York)’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.33M Sell
860,852
-500,000
-37% -$5.38M 0.42% 47
2025
Q4
$14.6M Buy
1,360,852
+250,000
+23% +$2.67M 0.61% 29
2025
Q3
$11.8M Sell
1,110,852
-50,000
-4% -$529K 0.54% 40
2025
Q2
$12.2M Hold
1,160,852
0.64% 32
2025
Q1
$12M Buy
1,160,852
+250,852
+28% +$2.57M 0.62% 31
2024
Q4
$9.23M Buy
910,000
+360,000
+65% +$3.64M 0.5% 38
2024
Q3
$5.53M Buy
+550,000
New +$5.51M 0.24% 56

Other funds holding GPAT

Westchester Capital Management (New York)'s GPAT Position: Q1 2026 in Review

Westchester Capital Management (New York) reduced its GP-Act III Acquisition Corp (GPAT) stake by 37% in Q1 2026, selling an estimated $5.38M and leaving 860,852 shares worth $9.33M. The position accounts for 0.42% of the portfolio, ranked #47.

Westchester Capital Management (New York) first reported a position in GPAT in Q3 2024 and has held it in 7 quarters since. The position peaked at $14.6M in Q4 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Westchester Capital Management (New York) held 860,852 shares of GP-Act III Acquisition Corp worth $9.33M as of Q1 2026.
  • Westchester Capital Management (New York) sold 500,000 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $5.38M.
  • GP-Act III Acquisition Corp made up 0.42% of Westchester Capital Management (New York)'s portfolio in Q1 2026, its #47 holding.
  • Westchester Capital Management (New York) first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 7 quarters since.
  • Westchester Capital Management (New York)'s GP-Act III Acquisition Corp position peaked at $14.6M in Q4 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.